Abstract
The development and standardization of the Women's Health Questionnaire (WHQ) is described. The questionnaire is reliable and has reasonable concurrent validity. It is sensitive to detecting change; this has been evaluated in both hormone replacement therapy studies and studies of non medical treatments. The WHQ is currently being used in a wide range of studies in Europe and North America. It is available in several European languages. Current applications include the evaluation of a health education intervention, evaluation of prospective hormone replacement therapy trials and a psychometric and cultural comparison of responses to the WHQ in several European countries.
Similar content being viewed by others
References
Hunter MS. The Women's Health Questionnaire: A measure of mid-aged women's perceptions of their emotional and physical health. Psychol & Health 1992a; 7: 45–54.
Snaith RP, Bridge GWK, Hamilton M. The Leeds' Scales for the self-assessment of anxiety and depression. Brit J Psychiatry 1976; 128: 156–165.
Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press, 1972.
Finlay-Jones RA, Murphy E. Severity of psychiatric dis-order and the 30-item general health questionnaire. Brit J of Psychiatry 1979; 134: 604–616.
Noyes R, Reich J, Clancy J, O'Gorman TW. Reduction in hypochondriasis with treatment of panic disorder. Brit J Psychiatry 1986; 149: 631–635.
Liao KLM, Hunter M, Weinman J. Health-related behaviours and their correlates in a general population sample of 45 year old women. Psychol & Health 1995; 10: 171–184.
Liao KLM, Hunter MS. Preparation for the menopause: prospective evaluation of a health education intervention for mid-aged women. Maturitas 1998; 29: 215–224.
Bebbington PE, Hurry J, Tennant C, Sturt E, Wing JK. The epidemiology of mental disorders in Camberwell. Psychol Med 1981; 11: 561–580.
Hunter MS. Gynaecology. In: Bass C (ed) Somatization: Physical Symptoms and Psychological Illness, London: Blackwell Scientific Publications, 1990.
Wiklund I, Gerg G, Hammar M, Karlberg J, Lingren R, Sandin K. Long-term effects of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 1992; 14: 225–236.
Wiklund I, Karlberg J, Mattson L-A. Quality of life during transdermal oestradiol therapy in postmenopausal women: A double blind placebo controlled study. Am J Obstet & Gynaecol 1993; 168: 824–830.
Limouzin-Lamothe M-A, Mairon N, Joyce CRB, Le Gal M. Quality of life after the menopause: influence of hor-monal replacement therapy. Amer J Obstet & Gynaecol 1994; 170: 618–624.
Wiklund I. Methods of assessing the impact of climac-teric complaints on quality of life. Maturitas 1998; 29: 41–50.
Hunter MS, Liao KLM. Evaluation of a four-session cog-nitive-behavioural intervention for menopausal hot flushes. Brit J Health Psychol 1996; 1: 113–125.
Hunter MS. The S.E. England longitudinal study of the climacteric and postmenopause. Maturitas 1992b; 14: 117–126.
Hunter MS, O'Dea I. An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health. Patient Educ & Counsell 1999; 38: 249–255.
Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy and exercise participation. Health Psychol 1997; 16: 203–208.
Vickers M. Women's International Study of long duration oestrogen after menopause – WISDOM update. J Brit Menopause Soc 1999; 5: 159.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, M. The Women's Health Questionnaire (WHQ): The development, standardization and application of a measure of mid-aged women's emotional and physical health. Qual Life Res 9 (Suppl 1), 733–738 (2000). https://doi.org/10.1023/A:1008973822876
Issue Date:
DOI: https://doi.org/10.1023/A:1008973822876